Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_4
2
29%
Ph phase_1
1
14%
Ph phase_2
3
43%

Phase Distribution

1

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Other(1)

Detailed Status

Completed4
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
Phase 31 (14.3%)
Phase 42 (28.6%)

Trials by Status

recruiting229%
unknown114%
completed457%

Recent Activity

2 active trials
Showing 5 of 7
recruitingphase_2

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

NCT05940324
recruitingphase_3

Emergency Department-Initiated Medications for Alcohol Use Disorder

NCT05827159
completedphase_2

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

NCT05093296
completedphase_4

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

NCT05037032
completedphase_2

Fibromyalgia and Naltrexone: The FINAL Study

NCT04270877
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT05940324Phase 2

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Recruiting
NCT05827159Phase 3

Emergency Department-Initiated Medications for Alcohol Use Disorder

Recruiting
NCT05093296Phase 2

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder

Completed
NCT05037032Phase 4

Effects of Naltrexone on Nocturnal Breathing Patterns at Altitude

Completed
NCT04270877Phase 2

Fibromyalgia and Naltrexone: The FINAL Study

Completed
NCT05228418Phase 4

Bridging ED to Outpatient AUD Therapy With Naltrexone

Unknown
NCT04250792Phase 1

Efficacy of Low Dose Naltrexone in Psoriasis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7